|Articles|April 1, 2018
- Applied Clinical Trials-04-01-2018
- Volume 27
- Issue 4
Applied Clinical Trials, April 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials April 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Barriers and Solutions to Smart Clinical Program Designsover 7 years ago
MythBusting: 6 eConsent Myths we Need to Correct in 2018over 7 years ago
Eli Lilly Joins the Force on Clinical Trial Patient Educationover 7 years ago
The Pull and Tug on Orphan Drug Developmentover 7 years ago
The Commedia Dell'Arte of the EMA Relocationover 7 years ago
Patient Input into Leveraging the Healthcare Professional’s Roleover 7 years ago
The Impetus for Natural History Studies in Rare Disease R&Dover 7 years ago
All in Our Heads? The Power of Placebo ResponseNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
Using AI and Tokenized Data to Match Patients to Protocols
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
